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Abstract
Background: Persistent sub-threshold depressive symptoms are important because almost all patients who
experience symptoms for more than 2 years go on to develop major depressive episodes. The National Institute
for Health and Care Excellence in the United Kingdom recommends research into the efficacy of person centred
counselling and low-intensity cognitive behavioural therapy for persistent sub-threshold and mild depression.
Methods/design: A two-arm, parallel group, pilot randomised trial to test the key components of trial delivery.
The participants will be 50 patients with the diagnosis of persistent sub-threshold depressive symptoms and mild
depression, recruited at five general practices in Glasgow, Scotland. Eligible patients will be randomised to receive
either Person-Centred Counselling (PCC) or Low-Intensity Cognitive Behavioural Therapy (LI-CBT). The primary
outcome measures are recruitment, adherence and retention rates at six months from baseline. The secondary
outcome measures are changes at 6 months on GRID-HAMD-17; recovery from, or prevention of, depression
according to DSM-IV diagnosis at 6 months; changes at 6 months on the PHQ-9, WSAS, EQ5D, and SF12v2 MH
Enhanced.
We will provide estimates, with adequate precision, to help design future studies, of the recruitment rate and the
proportion followed-up at 6 months; and identify potential moderators of outcome.
Discussion: Evidence of comparative effectiveness of commonly used psychological treatments such as
person-centred counselling and low intensity cognitive behavioural therapy is lacking in patients with sub-threshold
and mild depression. This study will provide the information needed to construct a trial comparing these two
treatments. This would help to inform early intervention treatment strategies for these conditions.
Trial registration: Current Controlled Trials ISRCTN Register ID: ISRCTN60972025
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Randomised controlled trial; Pilot study
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Introduction
Depression is a major public health problem that causes
significant costs to individuals and society (Cassano and
Fava 2002). It is associated with poor quality of life, im-
paired interpersonal and family relationships, occupational
disadvantage, residual disability, and suicide (Thornicroft
and Sartorius 1993). Almost 800,000 consultations for psy-
chological signs and symptoms (mainly depression and/or
anxiety) were conducted in general practice in Scotland in
2012 – 13 (Information and Statistics Division Scotland
2013). Persistent depressive symptoms below the thresh-
old for major depression cause chronic illness and have a
high risk of progression (Goldberg and Huxley 1992). Al-
most all patients with sub-threshold depressive symptoms
lasting longer than 2 years eventually develop major de-
pressive episodes (Klein et al. 2000).
Rationale for the Study
The National Institute for Health and Care Excellence
(NICE) (National Institute for Clinical Excellence 2009) rec-
ommends establishing if counselling and low-intensity cog-
nitive behavioural interventions are effective alternatives
to treatment as usual, in the management of persistent
sub-threshold depressive symptoms and mild depression.
Depressive symptoms are ‘persistent’, if they continue
despite active monitoring and/or low-intensity inter-
vention, or have been present for a considerable time.
NICE recommends a non-inferiority trial design, using
both observer and patient-rated assessments of improve-
ment, and reporting short and medium-term outcomes of
at least 18 months duration. The Scottish Intercollegiate
Guidelines Network (SIGN) similarly recommends research
on the long-term effectiveness of non-pharmaceutical inter-
ventions for depression (Scottish Intercollegiate Guidelines
Network 2010).
Person-centred counselling (PCC), also known as non-
directive therapy or Rogerian therapy, is the most common
psychological intervention offered in community settings
in the UK (Mellor-Clark et al. 2001). PCC focuses on pro-
viding an empathic, accepting, and genuine therapeutic
relationship, which aims to foster clients’ inner capacities
and resources, promoting positive change (Rogers 1951).
Evidence, from a number of trials in the UK comparing
counselling with usual GP care for patients with depres-
sion, suggests that counselling is superior to standard GP
care with an effect size of 0.5 to 0.6, with the strongest ef-
fects in the short term (Bower and Rowland 2006).
Low intensity Cognitive Behavioural Therapy (CBT)
guided self-help is recommended by NICE and SIGN for
mild to moderate depression. Guided self-help CBT is
considered a low intensity (LI) intervention because the
amount of practitioner time is limited, compared to
traditional high intensity (HI) expert-led treatments.
Guided self-help CBT can be delivered through books,
classes, computers and online resources (Williams and
Morrison 2010). A review of the efficacy of treatments for
depression found the overall effect of guided CBT self-
help interventions was 0.8, (95% CI 0.58 – 1.01) with im-
proved results when support or guidance was provided
(Gellatly et al. 2007). A recent meta-analysis suggested
equivalent outcomes for expert delivered CBT and for
guided CBT self-help for depression (Cuijpers et al. 2010).
NICE also recommends assessment of the acceptability
of the treatment options and the investigation of moder-
ator variables affecting outcomes. A recent meta-analysis
of patients’ preferences found that patients who were
matched to their preferred talking therapy were less
likely to drop out of therapy and had better outcomes
(Swift et al. 2011). There is also a small but significant
positive effect of patient prior expectation on successful
treatment outcome (Constantino et al. 2011). In addition,
about 85% of adults with depression experience signifi-
cant symptoms of anxiety and their presence results in
less positive treatment outcomes (Gorman 1997). Finally,
patients with high alexithymia (i.e., difficulty in per-
ceiving, differentiating, and expressing emotions) obtain
less favourable outcomes from psychological therapies
(McCallum et al. 2003).
Methods/design
Study Aims
This study aims to test the feasibility of a randomised
controlled trial of the clinical and cost effectiveness of
Low Intensity Cognitive Behaviour Therapy (LI-CBT)
and Person-Centred Counselling (PCC) for patients with
persistent sub-threshold depressive symptoms and mild
depression. It will provide estimates for the recruitment,
adherence, and retention rates, as well as estimates of
the variability of outcome measures to inform power cal-
culations for a definitive trial. Estimates of comparative
intervention effects will be produced, but this study is
not designed to have sufficient power to detect differ-
ences, nor to demonstrate non-inferiority between inter-
ventions. It will also:
 Test the feasibility of measuring alexithymia,
anxiety, preference for treatment, and outcome
expectations as potential moderators of outcomes.
 Identify other factors that are potential moderators
of outcomes.
 Test the feasibility of carrying out adherence/
competence checks of the treatments delivered.
 Identify the feasible and necessary data to collect for
a cost-effectiveness comparative analysis.
It will consider a range of variables at baseline as pos-
sible moderators (e.g., chronicity and severity of depres-
sive symptoms and demographic variables). Finally, this
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study will help to identify any potential problems that
will need to be addressed before a definitive trial.
Type of study
This study is a two-arm, parallel group, randomised trial that
will be performed according to the Research Governance
Framework for Health and Community Care (Second edition,
2006) (Department of Health 2005). A two-arm design
was adopted rather than a three-armed study with a con-
trol/usual care comparator. This was decided after discus-
sion with the funder who was concerned that a three arm
trial would be unnecessarily complex with little chance of
testing out moderator variables. A two–arm study would
have lower cost and more power to compare the relative
cost-effectiveness of the interventions.
Research questions
Primary research question:
What are the likely recruitment, adherence, and reten-
tion rates over six months for a trial comparing PCC with
LI-CBT in primary care for persistent sub-threshold and
mild depression?
Secondary research questions:
(1) What sample size would be required for a larger
comparative study of short-term (6 months)
outcomes between PCC and LI-CBT in primary
care for persistent sub-threshold and mild
depression?
(2) What is the feasibility of measuring alexithymia,
anxiety, preference for treatment, and outcome
expectations as potential moderators of outcomes?
(3) What other factors can be identified as potential
moderators of outcomes?
(4) What is the feasibility of carrying out adherence/
competence checks of the treatments delivered?
(5) What data are feasible and necessary to collect for a
cost-effectiveness comparative analysis?
Outcome measures
The primary outcome measures are recruitment, adher-
ence and retention rates at six months from baseline.
The secondary outcome measures are:
1. Changes at 6 months on GRID-HAMD-17 (Williams
et al. 2008)
2. Recovery from, or prevention of, depression according
to DSM-IV (American Psychiatric Association 2000)
diagnosis at 6 months;
3. Changes at 6 months on the Patient Health
Questionnaire – 9 (PHQ-9) (Spitzer et al. 1999),
Work and Social Adjustment Scale (WSAS) (Mundt
et al. 2002), Euroquol (EQ5D) (The EuroQuol
Group 1990), and SF12v2 MH Enhanced (Mariush
and Turner-Bowker 2009
Evaluations at baseline, 3 and 6 months will all be con-
ducted in person between the research assistant and sub-
ject and are summarised in Table 1.
In addition to the primary and secondary outcome mea-
sures described above, we will also collect additional data
to help us to assess the feasibility of the study and describe
potential moderators. The measures used to collect these
additional data include: a Sociodemographic Questionnaire
for participants; a Questionnaire for Non-Participants
about their reasons for declining participation; Structured
Clinical Interview for DSM Disorders (SCID) interview
(First et al. 1997); the Client Service Receipt Inventory
(CSRI) (Chisholm et al. 2000); the Toronto Alexithymia
Scale (Bagby et al. 1994); a Therapy Attitude Form to
assess their prior views about therapy; a Questionnaire
for Research Evaluation to assess views about the re-
search process; Client Satisfaction Questionnaire ver-
sion 8 (CSQ – 8) (Larsen et al. 1979); a Questionnaire
for Non-Completers of the intervention to assess their
reasons for non-completion; a Questionnaire for Feedback
about their Therapy; a Change Interview with a sub-
sample; and a Questionnaire about their Prior Experience
with Psychological Treatment.
Statistical power
6.1 Sample size
Fifty participants (two groups of 25) will be randomised
to estimate recruitment, adherence, and retention rates,
as well as the variance of outcome measures. This will
provide estimates, with adequate precision to help de-
sign future studies, of the recruitment rate (e.g. if 100
people are offered participation in the study, the recruit-
ment rate will be 50% with a 95% confidence interval (CI)
of 40-60%) and the proportion followed-up at 6 months
(e.g. if 40 participants are retained in the study at
6 months, the retention rate of 80% will have a 95% CI of
67-89%). The study is not designed to have power to de-
tect differences in outcomes between groups. If 40 partici-
pants provide outcome data (20 per group) the study
would only be able to detect a mean between-group differ-
ence of 0.91 standard deviation (SD) units with 80%
power. Since both interventions are expected to have
some benefits, a between-group difference of this magni-
tude is unlikely. Within groups, however, there will be
80% power to detect a mean pre-post change of 0.66 SD
units in each group separately, or a mean change of 0.45
SD units in the two groups combined; note that these ef-
fect sizes relate to the SD of within-group changes, which
are likely to be smaller than the SD of a single measure-
ment. The study is likely, therefore, to detect moderate
improvements in outcomes over time within groups; these
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estimates will help inform the design of a larger, definitive
study.
Participants and their recruitment
Fifty people with the diagnosis of persistent sub-threshold
depressive symptoms and mild depression will be re-
cruited at five general practices in Glasgow, Scotland. Eli-
gibility to enter the trial will be confirmed at the baseline
assessment by the researcher.
Identification of participants and screening for eligibil-
ity will occur in two stages:
(i). Participants will be initially screened at the GP
practice by completing the self-report measure
PHQ-9. Participants scoring 5–18 on the PHQ-9
(i.e. mild or moderate low mood) will be potentially
eligible for the study. The GPs in the participating
surgeries will be asked to screen the list of potentially
eligible participants identified in their surgery to
exclude anyone who meets the exclusion criteria for
the study, or who they consider is unable to take part
in either of the interventions.
(ii).The potentially eligible participants identified in the
initial screening and not screened out by the GP,
will attend the baseline assessment with a
researcher. Eligibility to enter the trial will then be
assessed by the researcher using a structured
clinical interview (SCID).
Inclusion and exclusion criteria
The inclusion criteria are: written informed consent ob-
tained; aged ≥ 16; scoring 5-18 on the Patient Health
Questionnaire (PHQ-9) (i.e. mild or moderate low mood)
at screening; screened positive for persistent (i.e., > 6
months) sub-threshold depressive symptoms or mild
depression using the SCID; and capable of taking part
in research procedures. Exclusion criteria are: alcohol/
substance dependence; receiving other psychological
intervention; bipolar disorder; bereavement as presenting
issue; Post-Traumatic Stress Disorder (PTSD); cognitive
impairment; unable to understand, speak, read or write in
English; Terminal illness; and unable to take part in any of
the interventions.
Ethical considerations and consent
The study received a favourable ethical opinion from
Greater Glasgow and Clyde Ethics Committee REF: 12/
WS/0173.
Patients’ informed consent will be obtained for each of
the three stages of participation in the trial:
(1) Initial screening
(2) Assessment of eligibility to take part in the trial
(3) Participation in the randomised part of the trial
(1) When patients arrive in the GP surgery, they will re-
ceive a pack with study information from the surgery’s re-
ceptionist or, where automated check-in systems are in
place, the researcher. The pack will contain: short leaflet
information, study information sheet, demographic ques-
tionnaire, PHQ-9, and initial consent form to retain this
screening information (part 1 of consent form). A re-
searcher may be present in the surgery to answer questions
from patients. Patients will receive the researcher’s contact
information and will be invited to contact the researcher if
they have any questions about the research. Patients will
have the option of taking materials away along with a reply
paid envelope to return them by post or to return the com-
pleted questionnaires and consent form to a box at the
practice. Care will be taken not to coerce into completing
Table 1 Measures taken during the study
Screening Baseline 3 months 6 months
• PHQ-9. • SCID interview • PHQ-9 • PHQ-9
• Sociodemographic Questionnaire. • GRID-HAMD-17 • SCID • SCID
• Questionnaire for Non-Participants –
reasons for not taking part.
• PHQ-9 • GRID-HAMD-17 • GRID-HAMD-17
• GAD-7 • EQ-5D-5L • EQ-5D-5L
• WSAS • SF-12v2 MH Enhanced • SF-12v2 MH Enhanced
• CSRI (baseline and demographics) • WSAS • WSAS
• EQ5D-5L • Adapted CSRI (employment) • Adapted CSRI (employment)
• SF12 v2 MH Enhanced • Questionnaire for Research Evaluation • Questionnaire: Prior Experience
with Psychological Treatment
• Toronto Alexithymia Scale • CSQ-8
• Therapy Attitude Form • Questionnaire Therapy Feedback
• Questionnaires for Non-Completers
• Change Interview (sub-sample)
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the screening questionnaires and signing the consent form
for retaining this screening information. The receptionist
and researcher will be instructed not to exert any pressure
on the patients to return the questionnaires completed and
when the researcher is present in the surgery he or she will
answer questions about the study only if approached by
the potential participant.
Potentially eligible participants identified by the initial
screening, and not screened out by the GP, will then be
contacted and invited to attend an appointment with a
researcher. Those patients will receive a letter confirm-
ing the appointment which will include the full trial in-
formation leaflet for them to read. There will usually be
a minimum of 48 hours between receiving the informa-
tion leaflet and the appointment with the researcher. At
this appointment, the researcher will take the participant
through the information sheet and the patient will be
given the opportunity to ask any questions they have. At
this appointment:
(2) All patients will be asked to give written informed
consent to be assessed for their eligibility to take part in
the trial (part 2 of consent form) and
(3) If they are eligible to take part in the trial, they will
be asked to give written informed consent for their par-
ticipation in the trial (part 3 of consent form).
We will recruit participants in primary care; patients
will therefore not be detained under the Mental Health
Act and we will only recruit patients who have the cap-
acity to give informed consent.
Participants will be made aware at the outset that partici-
pation is voluntary and that they are free to leave the study
at any time without their standard care being affected.
Randomisation
At the end of the baseline assessment, all eligible and con-
senting participants will be randomly allocated by the
researcher to one of the two treatments through a re-
mote telephone randomisation system, after entering the
necessary baseline participant information. Randomisation
will be by means of a computer-generated code. Use
of an automated telephone randomisation system will
ensure concealment of allocation. Participants will be
randomised individually in blocks of length 4, strati-
fied by practice to balance practice level effects. The re-
searcher will inform (eligible and consenting) patients of
the outcome of randomisation at the end of the baseline
interview.
Withdrawal of subjects
The interventions are both widely used within primary
care in the NHS. Any potential risks are minimal. All
participants for the duration of the trial will continue to
be under the care of their GP who will be able to moni-
tor for any adverse effects. In addition, a policy for
responding to expressions of suicidal plans has been for-
mulated. If at any time the researcher believes that there is
a significant suicide risk with a patient who is participating
in the study, which has not been communicated to their
GP, the researcher will ask the patient for their consent to
pass this information on to their GP. If the patient with-
holds permission for their GP to be notified, the re-
searcher will consult the appropriate clinician (or
nominated deputy) at the research site. This person will
examine the patient’s data and, if it is considered neces-
sary, will assess the patient. If it is concluded that there is
a significant risk, the patient’s GP will be notified without
the patient’s consent. However, the nominated clinician
would contact the GP without first assessing the patient
him/herself if the situation was urgent, again with or
without the patient’s consent. The need to break confi-
dentiality in situations where there was significant concern
about harm to the individual (or others) will be explained
in the patient information leaflet.
If a participant withdraws from the study, no further
data will be collected. All data collected up to the point of
withdrawal will be retained. However, the individual’s per-
sonal details would be deleted from any computerised trial
records thus anonymising the retained data.
Interventions
Patients who are eligible for the study will be randomised
to receive either Person-Centred Counselling (PCC) or
Low-Intensity Cognitive Behavioural Therapy (LI-CBT).
Person-Centred Counselling (PCC)
Patients randomised to PCC will be offered eight weekly
sessions of person-centred counselling delivered by quali-
fied counsellors (minimum diploma-level training in PCC).
Counselling sessions will last 50 minutes and will take
place at the GP surgery or a university-based research
clinic, whichever is more convenient for the participant.
Prior to the trial, counsellors will receive brief refresher
training in PCC, following a therapy manual designed spe-
cifically for this trial based on the Skills for Health compe-
tence framework for Humanistic Psychological Therapies
(UCL 2009). All sessions will be audio-recorded with par-
ticipants’ consent and a random selection will be checked
for therapists’ adherence/competence by independent
researchers/practitioners using the Person-Centred and
Experiential Psychotherapy Scale (Freire et al. 2014); coun-
selors who fall below the minimum adherence cut-off of
3.5 will be given feedback and additional supervision.
Low-Intensity Cognitive Behavioural Therapy (LI-CBT)
Patients randomised to LI-CBT will receive a range of writ-
ten CBT self-help resources (Williams and Chellingsworth
2010) which are supported by an optional linked online
support course at http://www.llttf.com/. A DVD of the
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online support materials will be made available to partici-
pants without access to the Internet. Participants will re-
ceive telephone support over a series of up to eight
support sessions lasting 20 – 40 minutes. Guidance will
be delivered by trained support staff working with the
charity, Action on Depression Scotland. Support sessions
will follow a “Plan, Do, Review” structure which offers
structured yet personalised support (Williams 2007). All
sessions will be audio-recorded with participants’ consent
and a random selection will be checked for support staffs’
adherence/competence by independent researchers using
the Guided CBT Rating Scale31 (pg179). This ensures that
discussion is focused on introducing and supporting the
book-based resources and that delivery is provided in an
engaging and supportive way.
Data analysis
The Robertson Centre for Biostatistics, part of the Glasgow
Clinical Trials Unit, a fully registered UK CRN Clinical
Trials Unit, will manage and analyse trial data. All statis-
tical analyses will be conducted according to a pre-
specified Statistical Analysis Plan, to be agreed by the Trial
Management Group. Analyses will be largely descriptive,
though baseline-adjusted linear regression models (or
other regression models, as appropriate given the distribu-
tion of each outcome variable) will be used to estimate
intervention effect differences with 95% confidence inter-
vals, and to assess associations between potential moder-
ator variables and outcome measures.
Trial governance
Routine management of trial: Trial Management Group
The trial will be coordinated by the Trial Management
Group. The Trial Management Group will comprise all
co-investigators from all 3 sites. The role of the group is
to monitor all aspects of the conduct and progress of
the trial, ensure that the protocol is adhered to and take
appropriate action to safeguard participants and the
quality of the trial itself. The Trial Management Group
will meet on a monthly basis.
Trial steering committee
The Trial Steering Committee (TSC) will be established
in accordance with MRC guidelines and will include a
lay member (Medical Research Council 1998). The TSC
will provide overall supervision of the trial and ensure
that it is being conducted in accordance with the princi-
ples of Good Clinical Practice and the relevant regula-
tions. The TSC will:
 agree the trial protocol and any protocol
amendments
 provide advice to the investigators on all aspects of
the trial
 have members who are independent of the
investigators, in particular an independent
chairperson.
Decisions about continuation or termination of the
trial or substantial amendments to the protocol will be
the responsibility of the TSC.
Discussion
The NICE guidelines for depression state that “Psycho-
logical treatments are an important therapeutic option for
people with sub-threshold symptoms and mild depres-
sion” (National Institute for Clinical Excellence 2009).
They go on to indicate that low-intensity cognitive and be-
havioural interventions have the best evidence base but
even for these interventions the evidence is limited and
there is uncertainty about longer-term outcomes.
The evidence base is even less well established for
counselling and there is also a lack of evidence about
longer term outcomes for this treatment modality. Be-
fore a case can be made to provide these treatments in
the National Health Service, a randomised controlled trial
reporting short and medium-term outcomes (including
cost-effectiveness) is required, as NICE has recommended.
They have further indicated that such a trial should look
at the reproducibility of the treatment model; training and
supervision of those providing interventions; observer and
patient-rated assessments of improvement; an assessment
of the acceptability of the treatment options; clinically
important effects using a non-inferiority design; and me-
diators and moderators of response. This feasibility/pilot
study is the first step towards informing a large scale RCT
that addresses these requirements.
Recruitment is a challenge in studies of depression
and difficulties in recruiting patients into trials are well-
documented (Woodford et al. 2011). It is, therefore, im-
portant to determine likely recruitment and retention
rates for this group before embarking on a full-scale
trial. This pilot study will describe the recruitment, ad-
herence and retention rates at six months from baseline.
Trial status
Ongoing.
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